On January 19, 2017, Robert T. Conway, Jr. informed Calmare Therapeutics Incorporated of his decision to resign, effective immediately, from the company's Board of Directors. Mr. Conway was the Chairman of Nominating and Corporate Governance Committee and a member of Compensation Committee of the Board at the time of his resignation. The resignation was not the result of any disagreements with the Company. On January 19, 2017, Steve Roehrich informed the Company of his decision to resign, effective at the close of business on January 19, 2017, from the Company's Board. Mr. Roehrich was a member of Audit Committee and a member of the Nominating and Corporate Governance Committee of the Board at the time of his resignation. The resignation was not the result of any disagreements with the Company. On January 24, 2017, the Company's Board of Directors voted unanimously to reduce the number of board members from seven (7) to five (5).